376
RIWC 2022
21st Retina International World Congress
RIWC 2022
21st Retina International World Congress
Icelandic Association of the visually impaired (BIAVI)
SENA ehf
Hagasmári 1
201 Kópavogur
The RIWC2022 will be held at the same time and venue as NOK2022 is taking place.
-
Basisinformation
Datum09.06.2022 - 11.06.2022KongressReykjavíkSpracheEnglischGebühren ab21500.00 ISKVeranstalterBlindrafélagið
Icelandic Association of the visually impaired (BIAVI)OrganisatorSENA ehf
Hagasmári 1
201 Kópavogur -
VERANSTALTUNGSORT
HARPA Concert Hall and Conference Centre
Austurbakki 2
101 Reykjavík, IS -
Programm
Thursday 9th June
17:00 - 19:00
Welcoming ceremony
17:30 - 18:30
K.1.1 Keynote: Phenotyping and Genotyping in inherited retinal diseases. - Speaker: Prof. Bart Leroy, University of Ghent, Gent, Belgium. Ask to include Refsum and other metabolic diseases.Friday 10th June08:30-10:00
P.2.1 Age related macular Degeneration. - Moderator: Jóhann Ragnar Guðmundsson
08:30-08:50
The MacuStar project - Robert Finger, Department of Ophthalmology, University of Bonn, Germany - Confirmed08:50 – 09:05
AMD research at Oslo University Hospital: from LUCAS to compounding pharmacy and beyond.
Speaker: Professor Morten Carstens Moe, Oslo University Hospital, Oslo, Norway. Confirmed09:05 – 09:15 Off-label use of Avastin: Scandinavian disparities.
Speaker: Tomas Bro, MD, PhD, Höglandssjukhuset, Eksjö, Sweden Confirmed09:15 – 09:25 The risk of extending AMD treatment.
Speaker: David Epstein, MD, PhD. Sankt Erik Eye Hospital, Karolinska Institute, Stockholm, Sweden. ? Restrictions for travel09:25 – 09:35 The Swedish Macula Register.
Speaker: Inger Westborg, MD, PhD., Uppsala University Hospital, Uppsala, Sweden. Confirmed09:35 – 09:50 AMD Epidemiology and Genetics. What is important!
Speaker: Prof. emeritus Friðbert Jónasson, University of Iceland, Iceland. Confirmed. There will be a change of the title09:50 – 10:00 QnA.
08:30 – 10:00 L.2.1 Retinal degenerations. Clinical aspects.
Moderator: Dr. Prof. Elise Heon, The Hospital for Sick Children, Toronto, Canada.Confirmed
08:30 – 08:50 Clinical aspects of IRD.
Speaker: Prof. Dr. Elise Heon The Hospital for Sick Children, Toronto, Canada. Confirmed08:50 – 09:10 Clinical aspects of inherited macular degenerations.
Speaker: Dr. Line Kessel, Department of Ophthalmology, Rigshospitalet, Copenhagen, Denmark. Confirmed09:10 – 09:30 Syndromic forms of IRD.
Speaker: prof. Dr. Hélène Dollfus, CARGO, Hôpitaux Universitaires de Strasbourg, France. Confirmed09:30 – 09:50 The genetic testing landscape
Speaker: Avril Daly, Retina International, Dublin, Ireland Confirmed09:50 – 10:00 QnA.
10:00 – 10:30 Coffee break.
10:30 – 11:30 P.2.2 Assessment of Endpoints in clinical studies.
Moderators Dr. Cecilie Bredrup, Bergen, Norway and Prof. Sten Kjellström, Lund, Sweden. Confirmed
10:30 – 10:50 Experiences with Luxturna.
Speaker: Prof.Line Kessel, Department of Ophthalmology, Rigshospitalet, Glostrup, Denmark Confirmed10:50 – 11:10 Paediatric specificities in trials.
Speaker: Prof. Dr. Elise Heon, MD, The Hospital for Sick Children, Toronto, Canada. Confirmed11:10 – 11:30 Developing Patient Relevant Outcomes in Gene Therapy Trials: The Novel Functional Vision Endpoint, the Multi-luminance Mobility Test (MLMT).
Speaker: Dr. Daniel Chung, DO, MA, Philadelphia, USA Confirmed Daniel.chung@sparingvision.com
Where to put gene agnostic approaches?
10:30 – 11:30 L.2.2 Retinal degenerations – the genetics.
Moderator: Prof. Jón Jóhannes Jónsson, national University Hospital, Reykjavík, Iceland. Confirmed
10:30 – 10:50 Pattern of inheritance – easy to understand.
Speaker: Dr. Eirný Þórólfsdóttir National University Hospital, Reykjavík, Iceland. Confirmed10:50 – 11:10 Understanding the results – a difficult task.
Speaker: Prof. Jón Johannes Jónsson, national University Hospital, Reykjavík, Iceland.Confirmed11:10 – 11:20 Lessons from Iceland on the diversity of genetic causes. Speaker: Daníel Þorsteinsson. Confirmed
11:20 – 11:30 ABCA4 related IRDs
Speaker: Frans Cremers, Radboud University, Nijmegen, Netherlands Confirmed11:30 – 12:00 K.2.1 Keynote: Scientific results, a rollercoaster between hope and deception.
Speaker: Christina Fasser, former president of the Retina International, Zurich, Switzerland. Confirmed12:00 – 13:30 Lunch
13:30 – 14:00 K.2.2
Keynote: Innovations in Ophthalmology.
Dr. Sabri Markabi NOT confirmed. Masayo Takahashi?Yes, switch with Christina14:00 – 15:00 P.2.3 Phenotype-Genotype Correlations in IRD
Moderators: Josephine Prener Holtan MD, Oslo University Hospital, Oslo, Norway, and Prof. Bart Leroy, Ghent, Belgium. Confirmed
14.00 – 14.10 Natural history and clinical characterization of patients with retinitis pigmentosa caused by mutations in the PRPF31 gene.
Speaker: Kristian Lisbjerg, MD, Department of Ophthalmology, Copenhagen University Hospital, Denmark.Confirmed14.10 – 14.20 Genetic basis and phenotypic characterization of Danish patients with Achromatopsia.
Speaker: Mette K.G. Andersen,MD, Ophthalmologist at Department of Ophthalmology, Copenhagen University hospital, Rigshospitalet-Glostrup, Denmark.Confirmed14.20 – 14.35 Whole exome sequencing in the diagnosis of hereditary retinal disorders: A clinical perspective.
Speaker: Ragnhild Jansson Wivestad, MD, Department of Ophthalmology, Haukeland University Hospital, Norway. Confirmed14.35 – 15.00 ERN-EYE a booster for patients care and research for Rare Eye Diseases in Europe.
Speaker: Professor Helene Dollfuss, MD, PhD, Service de Génétique Médicale, Hôpital de Hautepierre, Strasbourg, France. Confirmed14:00 – 15:00 L.2.3 Basics of stem cell and gene-based therapies.
Moderator: Prof. Kapil Bharti. National Eye Institute, Bethesda, USA Confirmed 14:00 – 14:20 Overview of on-going clinical trials with stem cells
Speaker: Prof. Goran Petrovski.Confirmed 14:20 – 14:35 Stem Cell Based Trials for AMD
Speaker: Prof. Kapil Bharti. National Eye Institute, Bethesda, USA Confirmed 14:35 – 14:50 Clinical trial in opto-genetics.
Speaker: Prof. Isabelle Audo, INSERM, Paris, France. Confirmed
14:50 – 15:00 How to discriminate between real treatments offers and quacks.Speaker: Martin Smedstad Oslo, Norway. Change title 15:00 – 15:30 Coffee break.
15:30 – 16:00 K.2.3
Keynote: Restoration of vision
Speaker: Prof. Mark S. Humayun University of Southern California, Los Angeles, USA. Confirmed16:00 – 17:00 P.2.4. Innovations in Ophthalmology.
Moderators: Christina Fasser and Prof. Einar Stefánsson. Program not ready
16:00 – 17:00 L.2.4 Rehabilitation and mobility training. Session confirmed Moderators: Vala Jóna Garðarsdóttir and Rósa María Hjörvar Iceland.
16:00 – 16:15 Mobility training and mobility tools.
Speaker: Vala Jóna Garðarsdóttir. National institute for the blind in Iceland.16:15-16:30 Reading with auxiliary aids.
Speaker: Rósa María Hjörvar. PhD student in Literature at the University of Iceland.16:30-16:45 The assistive technology, aps etc.
Speakers: Baldur Snær Sigurðsson and Hlynur Þór Agnarsson.16:45 – 17:00 Coping with visual and hearing impairment.
Speakers: Halla Dís Hallfreðsdóttir and Elín Yr Hafdisardóttir Arnardóttir.Saturday 11th June08:30–10:00 P.3.1 New Developments in IRD.
Moderator: Prof. Michael Larsen. Confirmed
08:30-08:50 Accessing Genetic Testing for IRDs: The Patient Perspective.Speaker: Fiona Waters, Retina International, Dublin, Ireland Confirmed 08:50-09:10 ABCA4 retinal dystrophies
Speaker: Frans Cremers, Radboud University, Nijmegen, Netherlands Confirmed 09:10- 09:30 Ragnheidur Bragadottir and Josephine Prener Holtan: Luxturna treatment
in Norway Confirmed
09:30-10:00 Masayo Takahashi: the first clinical trial with iPScells Takahashi as keynote, Koenekoop instead: Gene therapy of Choroideraemia and X-linked retinitis pigmentosa – lessons to be learned. Confirmed
08:30-10:00 L.3.1 Clinical trials and therapies from a patient’s perspective.
Moderator: Martin Smedstad, Oslo, Norway. Is session confirmed? 08:30 – 08:50 Overview and future on on-going clinical trials.
Speaker Prof. Dr. Elise Heon, MD, The Hospital for Sick Children, Toronto, Canada. 08:50 – 09:10 RPE65 – the first gene therapy on the market.
Speaker: Dr. Daniel Chung, Philadelphia, USA. Change to Line Kessel 09:10 – 09:30 Oligonucleotides – a hope for all?
Speaker: Prof. Bart Leroy, Gent University, Ghent, Belgium. Confirmed 09:30 – 09:50 My personal experience of gene therapy.
Speaker: Camilla Jensen, Oslo, Norway Not formally confirmed 10:00 – 10.30 Coffee break.
10:30 – 12:00 P.3.2 Stem cells and cell-based therapies of retinal diseases. Moderator Dr. Goran Petrovski, Oslo, Norway. Confirmed
10;30 – 10:45: Initiating a Phase I/IIa clinical trial for an autologous iPS cell therapy for macular degeneration: from bench-to-bedside.
Speaker: Prof. Kapil Bharti (NIH/NEI), Bethesda, USA. Confirmed10:45 – 11:00 Towards stem cell-based therapy in retinal degeneration. Speaker: Anders Kvanta Stockholm, Sweden. Confirmed
11:00 – 11:30 Subretinal implantation of primary human RPE cells in minipig eyes. Speaker: Dr. Goran Petrovski, Oslo, Norway.
11:30 – 12:00 RB asks Koenekoop to give a presentation?
10:30 – 12:00 L 3.2 Retina International – the global challenges.
Moderator: Kristinn Halldor Einarsson, Iceland.
Christina and Avril will arrange the program
12:00 – 13:00 Lunch.
13:00 – 14:00 K.3.1 Keynote: Gene based therapies of retinal diseases. Speaker: Prof. Artur Cideciyan, University of Pennsylvania, Philadelphia, USA. Confirmed
14:00 – 15:00 P.3.3 Gene based therapies of retinal diseases.
Moderator Eeva-Marja Sankila, MD, PhD, Helsinki University Hospital, Helsinki, Finland. Send her e-mail14:00 – 14:15 CPK850 gene therapy in RLPB1 patients.
Speaker: Prof. Anders Kvanta, Karolinska Institute, Stockholm, Sweden Confirmed14:15 – 14:30 (Retinal gene therapy trials – investigators point of view.
Speaker: Eeva-Marja Sankila, MD, PhD, Helsinki University Hospital, Helsinki, Finland.) Sankila not willing to give a talk due to insufficient/disappointing results. Chung: Agnostic gene therapy approaches?14:30 – 14:45 Retinal gene therapy in choroideremia patients – surgical aspects. Speaker: Prof. Ilkka Immonen, Helsinki University Hospital, Helsinki, Finland.
14:45 – 15:00 Gene therapy of Usher syndrome.
Speaker: Prof. Isabelle Audo, Institute de la Vision, Paris, France. Confirmed14:00 – 15:00 L.3.4 Programme in Icelandic for the public. Kristinn will find panellists and a moderator
15:00 Closing ceremony. Zrenner confirmed
-
Gebühren
Fachärzte/-innenGebühren ab105.000,00 ISKEarly Bird bis 15.03.202285.000,00 ISKÄrzte/-innen in WeiterbildungGebühren ab26.500,00 ISKEarly Bird bis 15.03.202221.500,00 ISKStudenten/-innenGebühren ab26.500,00 ISKEarly Bird bis 15.03.202221.500,00 ISKRetina International members and patients fee: 37.000,00 ISK (EB), 43.000,00 ISK
Youth program participants fee: 21.000,00 ISK (EB), 26.500,00 ISK -
Buchung / Anmeldung
Please contact the organizer for further information.
You are the organizer?
Would you like to link your online registration here?
Please contact our sales team for an individual offer:
+49 (0) 30 403 6422-0 (phone) or info@eyefox.com (e-mail). -
Zertifizierung
Zertifizierung unbekannt